It is possible that in female APOE4+/- AD brains, reduction in LRP10 protein expression may result in an increased Aβ production with impaired APP trafficking [48] as well as a reduced Aβ clearance by microglia (as supported by our data) leading to AD pathological changes. Here, LRP10 is linked to Alzheimer disease.